July 18, 2014
/PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a
based topical generic drug development and manufacturing company, announced the Company will hold a conference call at
4:15 pm ET
Thursday, July 24, 2014
to discuss the 2nd quarter 2014 results.
The Company invites you to listen to the call by dialing 1-877-870-4263. International participants should call 1-412-317-0790. Canadian participants should call 1-855-669-9657. Participants should ask to be joined into the IGI Laboratories, Inc. call.
This call is being webcast by MultiVu (a PR Newswire Company) and can be accessed in the Investor Relations Section of IGI's website at
About IGI Laboratories, Inc.
IGI Laboratories is a generic topical pharmaceutical company. We develop and manufacture topical formulations for the pharmaceutical, OTC, and cosmetic markets. Our mission is to be a leading player in the generic topical prescription drug market.
SOURCE IGI Laboratories, Inc.